CN112479918B - Synthesis method of retinoic acid derivative Am580 - Google Patents

Synthesis method of retinoic acid derivative Am580 Download PDF

Info

Publication number
CN112479918B
CN112479918B CN202011457051.9A CN202011457051A CN112479918B CN 112479918 B CN112479918 B CN 112479918B CN 202011457051 A CN202011457051 A CN 202011457051A CN 112479918 B CN112479918 B CN 112479918B
Authority
CN
China
Prior art keywords
reaction
retinoic acid
acid derivative
stirring
hcl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN202011457051.9A
Other languages
Chinese (zh)
Other versions
CN112479918A (en
Inventor
董宏波
许丽佳
杜伟宏
巫敏
杨俊豪
史何飞
杨婷婷
王斌
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Chengdu University
Original Assignee
Chengdu University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chengdu University filed Critical Chengdu University
Priority to CN202011457051.9A priority Critical patent/CN112479918B/en
Publication of CN112479918A publication Critical patent/CN112479918A/en
Application granted granted Critical
Publication of CN112479918B publication Critical patent/CN112479918B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C231/00Preparation of carboxylic acid amides
    • C07C231/12Preparation of carboxylic acid amides by reactions not involving the formation of carboxamide groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C1/00Preparation of hydrocarbons from one or more compounds, none of them being a hydrocarbon
    • C07C1/26Preparation of hydrocarbons from one or more compounds, none of them being a hydrocarbon starting from organic compounds containing only halogen atoms as hetero-atoms
    • C07C1/28Preparation of hydrocarbons from one or more compounds, none of them being a hydrocarbon starting from organic compounds containing only halogen atoms as hetero-atoms by ring closure
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C231/00Preparation of carboxylic acid amides
    • C07C231/02Preparation of carboxylic acid amides from carboxylic acids or from esters, anhydrides, or halides thereof by reaction with ammonia or amines
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C51/00Preparation of carboxylic acids or their salts, halides or anhydrides
    • C07C51/16Preparation of carboxylic acids or their salts, halides or anhydrides by oxidation
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00Systems containing two condensed rings
    • C07C2602/02Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/14All rings being cycloaliphatic
    • C07C2602/26All rings being cycloaliphatic the ring system containing ten carbon atoms
    • C07C2602/28Hydrogenated naphthalenes
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

The invention discloses a synthesis method of a retinoic acid derivative Am580, which comprises the following steps: stirring 2, 5-dimethylhexane-2, 5-diol solution in concentrated HCl for 30min, introducing HCl gas into the system for reaction for 3h, stirring until the system becomes a two-phase mixture, cooling to room temperature, filtering to obtain a light pink solid, washing with water, recrystallizing in methanol, filtering to obtain intermediate 3 as white solid, dissolving 2, 5-dichloro-2, 5-dimethylhexane in organic solvent, dissolving AlCl into the solvent, and concentrating to obtain a solid 3 Adding into the solution, and adding the 2, 5-dichloro-2, 5-dimethylhexane and AlCl 3 The molar ratio of (2) is 1:0.1-1:0.2, heating to 100-120 ℃, stirring for 16h, quenching the reaction with 3M HCl, extracting the reaction product with n-hexane, and distilling the solvent under reduced pressure to obtain a colorless oily intermediate 4. The beneficial effects of the invention are as follows: the invention has higher yield per step, simple post-treatment and easy industrialized production; the method optimizes the reaction conditions and the solvent system aiming at Friedel-crafts reaction and oxidation reaction, and is more beneficial to industrial production.

Description

Synthesis method of retinoic acid derivative Am580
Technical Field
The invention relates to a drug synthesis process, in particular to a synthesis method of retinoic acid derivative Am580, and belongs to the technical field of medicine and health.
Background
The search for lead compounds from in vivo metabolites has been an important idea for scientific researchers to complete new drug development, and from the discovery of vitamin a for over one hundred years, people have discovered a series of lead compounds with biological activity such as Retinoic acid (Retinoic acid) and Retinoic acid derivatives through the research of metabolic pathways, action receptors and the like of vitamin a in human bodies, and many lead compounds are used for treating cancers and skin diseases (such as acne, psoriasis and the like). Although natural all-trans retinoic acid (all-trans retinoic acid) has good biological activity, the effective dose is relatively close to the toxic dose, the treatment window is small, tolerance can be generated after long-term use, and the defects of side effects such as teratogenesis, allergy and the like limit the wide clinical application range.
Since Kagechika et al in 1986 synthesized Am580, am580 has been receiving extensive attention from researchers due to its good and broad biological activity, such as the treatment of skin diseases, psoriasis, modulation of immune system, anticancer activity and the ability to reduce the risk of cardiovascular and cerebrovascular diseases. At present, more scientific researchers focus on the work of Am580 on the aspects of further modification and activity evaluation, and specific synthetic process routes of Am580 are freshly reported, so that the exploration of a high-efficiency and reliable synthetic route of Am580 has great significance for the research and development of new drugs and large-scale production. The method further improves and optimizes the original synthesis process through researching the existing synthesis route, and provides reference for large-scale production.
Am580, chemical name 4- [ [ (5, 6,7, 8-tetrahydro-5, 8-tetramethyl-2-naphtyl) carbonyl ] amino ] benzoic acid (1), its structural formula is
Figure GDA0003911632920000021
Literature (Arch. Pharm. Chem. Life Sci.2006,339, 193-200.) and patent EP 1541549, WO,2019/169270 starting from 1,2,3, 4-tetrahydro-1,1,4,4,6 pentamethylnaphthalene (4) via KMnO 4 Oxidizing, reacting with thionyl chloride to generate acyl chloride and then reacting with p-aminobenzeneAnd (3) condensing methyl formate and removing methanol. The raw materials used in the method are expensive, the cost of large-scale production is increased, and the method is not suitable for industrial production. There is also a literature (chi. J. Chem.2010,28, 1951-1956.) reporting that Am580 is obtained by starting from 2, 5-dimethyl-2, 5-hexanediol (2), reacting with HCl under acidic conditions to form 2, 5-dimethyl-2, 5-dichlorohexane (3), reacting with benzene to give starting material (4), and repeating the above steps. The method has the advantages of simple and easily obtained raw materials, lower yield and longer reaction time when the Friedel-crafts reaction and oxidation generate 5, 8-tetramethyl-5.6.7.8-tetrahydronaphthalene-2-carboxylic acid (5), and the industrial production needs to be further optimized.
Disclosure of Invention
The invention aims to solve the problems, and provides a synthesis method of a retinoic acid derivative Am580, which avoids complex post-treatment in the prior art and uses a cyclization reaction catalyst with higher cost; the post-treatment method is simplified, the catalytic system of the cyclization reaction is optimized, the reaction yield is improved, the environmental pollution is reduced, the production cost is saved, and the industrial mass production is facilitated.
The aim of the invention can be achieved by the following technical scheme: a synthesis method of a retinoic acid derivative Am580, which comprises the following steps:
step one: chlorination reaction
Stirring a solution of 2, 5-dimethylhexane-2, 5-diol in concentrated HCl for 30min, introducing HCl gas into a system for reaction for 3h, stirring until the system becomes a two-phase mixture, cooling to room temperature, filtering to obtain a light pink solid, washing with water, recrystallizing in methanol, and filtering to obtain an intermediate 3, wherein the product is a white solid;
step two: friedel-crafts reaction
Dissolving 2, 5-dichloro-2, 5-dimethylhexane in organic solvent, and dissolving AlCl 3 Adding into the solution, and adding the 2, 5-dichloro-2, 5-dimethylhexane and AlCl 3 The molar ratio of (2) is 1:0.1-1:0.2, heating to 100-120 ℃, stirring for 16h, quenching the reaction by using 3M HCl, extracting the reaction product by using n-hexane, and removing the solvent by reduced pressure distillation to obtain a colorless oily intermediate 4;
step three: oxidation reaction
Adding organic solvent, water, and alkali into a reaction vessel, and sequentially adding intermediate 4 and KMnO 4 Intermediate 4 is combined with alkali, KMnO 4 The molar ratio of (2) is 1:1.5:3-1:2.5:5, then the temperature is raised to 90-110 ℃ and the mixture is stirred for reaction for 16 hours, the reaction system is cooled to 10 ℃ by ice water bath, HCl is added, the pH=1 of the system is regulated, the product is extracted by ethyl acetate, and a white solid intermediate 5 is obtained after reduced pressure distillation;
step four: amidation reaction
Dissolving intermediate 5 in SOCl at 0deg.C 2 In the SOCl 2 10 times the mass of intermediate 5, 0.05-0.1ml DMF was added, stirred for 0.5h and then SOCl was removed in vacuo 2 Dissolving crude acyl chloride in an organic solvent, adding 4-ethyl aminobenzoate and DMAP, wherein the mol ratio of the DMAP to the 4-ethyl aminobenzoate is 1:10-1:12, heating the mixture at 60 ℃ for 2 hours under stirring, extracting with the organic solvent, and sequentially extracting an organic layer with HCl and saturated NaHCO 3 Washing with saturated NaCl, drying, filtering, and distilling under reduced pressure to obtain a white solid intermediate 6;
step five: hydrolysis reaction
Dissolving an intermediate 6 and KOH in methanol, wherein the molar ratio of the intermediate 6 to the KOH is 1:3-1:5, stirring for 15 hours under reflux, cooling to room temperature, distilling under reduced pressure to remove the solvent, adding the following organic solvent and water, regulating pH to be acidic by using an acid solution, separating an organic phase, and distilling under reduced pressure to remove the solvent to obtain a white solid target product 1, namely a retinoic acid derivative Am580;
the specific synthetic route of the retinoic acid derivative Am580 is as follows:
Figure GDA0003911632920000041
preferably, the organic solvent in the third step is one of toluene, chlorobenzene, chloroform and dichloromethane.
Preferably, the alkali in the third step is one of sodium hydroxide, potassium hydroxide, ammonia water, potassium carbonate and sodium carbonate.
Preferably, the reaction temperature in step two is 110 ℃.
Preferably, in the fifth step, the acid solution is any one of hydrochloric acid, sulfuric acid, phosphoric acid and acetic acid solution.
Preferably, the organic solvent in the fifth step is any one of tetrahydrofuran, ethyl acetate, dichloromethane, chloroform and toluene.
Compared with the prior art, the invention has the beneficial effects that:
1. the method has the advantages of higher yield per step, simple post-treatment, mild reaction conditions and easy industrialized production.
2. The method optimizes the reaction conditions and the solvent system aiming at Friedel-crafts reaction and oxidation reaction, and is more beneficial to industrial production.
Drawings
The present invention is further described below with reference to the accompanying drawings for the convenience of understanding by those skilled in the art.
FIG. 1 is a liquid chromatogram of retinoic acid derivative Am580 of the present invention.
Detailed Description
The technical solutions of the present invention will be clearly and completely described in connection with the embodiments, and it is obvious that the described embodiments are only some embodiments of the present invention, not all embodiments. All other embodiments, which can be made by those skilled in the art based on the embodiments of the invention without making any inventive effort, are intended to be within the scope of the invention.
Example 1: synthesis of Compound 3
Chlorination reaction
A solution of 2, 5-dimethylhexane-2, 5-diol (2) (14.6 g,0.10 mol) in concentrated HCl was stirred for 30min. And then HCl gas is introduced into the system to react for 3 hours. After stirring until the system became a two-phase mixture, cooling to room temperature, filtering to give a pale pink solid, washing with water, recrystallizing in methanol, and filtering to give compound 3 as a white solid (17.02 g, 93.1%).
Example 2: preparation of Compound 4
Friedel-crafts reaction
2, 5-dichloro-2, 5-dimethylhexane (3) (3 g,0.016 mol) was dissolved in toluene (80 mL) obtained by drying. AlCl is added 3 (0.22 g,1.64 mmol) was added to the solution, heated to 110deg.C and stirred for 16h, quenched with 3M HCl (10 mL), extracted with hexane (50 mL. Times.3), the combined organic phases were washed with saturated brine, anhydrous Na 2 SO 4 Drying and distillation under reduced pressure gave the product as a colourless oil (3.06 g, 92.6%).
Example 3: preparation of Compound 5
Oxidation reaction
Chlorobenzene (80 ml), H, was charged to a three-necked round bottom flask (250 ml) 2 O (20 ml) and NaOH (1.2 g,29.6 mmol). Compound 4 (3.00 g,14.8 mmol) and KMnO were added sequentially 4 (9.36 g,59.2 mmol). The reaction was heated and stirred at 100deg.C for 16h, then cooled to 10deg.C with ice-water bath, HCl (6N, 100 mL) was added to adjust pH=1, the product was extracted with ethyl acetate (3X 100 mL) and taken over Na 2 SO 4 Drying, filtration and distillation under reduced pressure gave white solid 5 (2.17 g, 63.3%).
Example 4: process for the preparation of Compound 6
Amidation reaction
Compound 5 (2.0 g,8.6 mmol) was dissolved in SOCl at 0deg.C 2 (20 mL). A few drops of DMF was added and after stirring for 0.5h SOCl was removed in vacuo 2 And the crude acid chloride was dissolved in pyridine (50 mL). Ethyl 4-aminobenzoate (1.5 g,9.9 mmol) and DMAP (0.10 mg,0.86 mmol) were added and the mixture was heated at 60℃for 2h with stirring. After water quenching, ethyl acetate extraction, the organic layer was successively quenched with HCl (2 mol/L), saturated NaHCO 3 Washing with saturated NaCl and then with anhydrous Na 2 SO 4 Drying, filtration and distillation under reduced pressure gave a white solid (2.45 g, 78.0%).
Example 5: process for the preparation of compound 1
Hydrolysis reaction
In a round bottom flask was charged compound 6 (1.0 g,2.74 mmol), meOH (40 mL) and KOH (0.62 g,11 mmol). The reaction mixture was stirred at reflux for 15h and cooled to room temperature before subtractionThe solvent was distilled off under pressure, ethyl acetate (30 ml) and water (20 ml) were added, the pH was adjusted to be acidic with HCl (6N) solution, and then the organic phase was separated, washed with saturated brine, na 2 SO 4 Drying, filtration and distillation under reduced pressure gave a white solid (0.78 g, 81.2%);
the specific synthetic route of the retinoic acid derivative Am580 is as follows:
Figure GDA0003911632920000061
test example 1
The nmr hydrogen spectrum and carbon spectrum of Am580 obtained in example 5 were measured as follows:
1 H NMR(600MHz,DMSO-d6)δ10.39(s,1H),7.95(d,J=10.3Hz,2H),7.91(d,J=10.3Hz,2H),7.88(d,J=2.2Hz,1H),7.70(dd,J=9.6,2.2Hz,1H),7.43(d,J=9.6Hz,1H),4.29(q,J=7.0Hz,2H),1.69(s,4H),1.31(t,J=7.1Hz,3H),1.30(s,6H),1.27(s,6H)。
test example 2
The liquid phase data for Am580 obtained in example 5 were determined as follows:
purity of liquid phase: 96.7%.
Note that: chromatographic conditions
Chromatographic column: waters X Bridge C18 reverse phase chromatography column: 50mm 4.6mm 3.5um; mobile phase: a: water (0.01 mol/L NH4HCO 3) B: acetonitrile; elution gradient: b:0-1.6min,5% -95%,1.6-2.5min,95%; flow rate: 2ml/min; column temperature: 40 ℃.
The preferred embodiments of the invention disclosed above are intended only to assist in the explanation of the invention. The preferred embodiments are not intended to be exhaustive or to limit the invention to the precise form disclosed. Obviously, many modifications and variations are possible in light of the above teaching. The embodiments were chosen and described in order to best explain the principles of the invention and the practical application, to thereby enable others skilled in the art to best understand and utilize the invention. The invention is limited only by the claims and the full scope and equivalents thereof.

Claims (6)

1. A synthesis method of a retinoic acid derivative Am580 is characterized in that: the method comprises the following steps:
step one: chlorination reaction
Stirring a solution of 2, 5-dimethylhexane-2, 5-diol in concentrated HCl for 30min, introducing HCl gas into a system for reaction for 3h, stirring until the system becomes a two-phase mixture, cooling to room temperature, filtering to obtain a light pink solid, washing with water, recrystallizing in methanol, and filtering to obtain an intermediate 3, wherein the product is a white solid;
step two: friedel-crafts reaction
Dissolving 2, 5-dichloro-2, 5-dimethylhexane in an organic solvent, adding AlCl3 into the solution, heating to 100-120 ℃ and stirring for 16 hours, then quenching the solution by using 3M HCl, extracting the solution by using n-hexane, and removing the solvent by reduced pressure distillation to obtain a colorless oily intermediate 4;
step three: oxidation reaction
Adding organic solvent, water, and alkali into a reaction vessel, and sequentially adding intermediate 4 and KMnO 4 Intermediate 4 is mixed with alkali, KMnO 4 The molar ratio of (2) is 1:1.5:3-1:2.5:5, then the temperature is raised to 90-110 ℃ and the mixture is stirred for reaction for 16 hours, the reaction system is cooled to 10 ℃ by ice water bath, HCl is added, the pH=1 of the system is regulated, the product is extracted by ethyl acetate, and a white solid intermediate 5 is obtained after reduced pressure distillation;
step four: amidation reaction
Dissolving intermediate 5 in SOCl at 0deg.C 2 In the SOCl 2 10 times the mass of intermediate 5, 0.05ml-0.1ml DMF was added, stirred for 0.5h and then SOCl was removed in vacuo 2 Dissolving crude acyl chloride in an organic solvent, adding 4-ethyl aminobenzoate and DMAP, wherein the mol ratio of the DMAP to the 4-ethyl aminobenzoate is 1:10-1:12, heating the mixture at 60 ℃ for 2 hours under stirring, extracting with the organic solvent, and sequentially extracting an organic layer with HCl and saturated NaHCO 3 Washing with saturated NaCl, drying, filtering, and distilling under reduced pressure to obtain a white solid intermediate 6;
step five: hydrolysis reaction
Dissolving an intermediate 6 and KOH in methanol, wherein the molar ratio of the intermediate 6 to the KOH is 1:3-1:5, stirring for 15 hours under reflux, cooling to room temperature, removing the solvent by reduced pressure distillation, adding an organic solvent and water, adjusting pH to be acidic by an acid solution, separating an organic phase, and removing the solvent by reduced pressure distillation to obtain a white solid target product 1, namely a retinoic acid derivative Am580;
the specific synthetic route of the retinoic acid derivative Am580 is as follows:
Figure FDA0003911632910000021
2. the method for synthesizing retinoic acid derivative Am580 according to claim 1, wherein the organic solvent in step three is one of toluene, chlorobenzene, chloroform and dichloromethane.
3. The method for synthesizing retinoic acid derivative Am580 according to claim 2, wherein the alkali in the third step is one of sodium hydroxide, potassium hydroxide, ammonia water, potassium carbonate and sodium carbonate.
4. The method for synthesizing retinoic acid derivative Am580 according to claim 1, wherein the reaction temperature in the second step is 110 ℃.
5. The method for synthesizing retinoic acid derivative Am580 according to claim 2, wherein the acid solution in the fifth step is any one of hydrochloric acid, sulfuric acid, phosphoric acid and acetic acid solution.
6. The method for synthesizing retinoic acid derivative Am580 according to claim 1, wherein the organic solvent in the fifth step is any one of tetrahydrofuran, ethyl acetate, dichloromethane, chloroform and toluene.
CN202011457051.9A 2020-12-11 2020-12-11 Synthesis method of retinoic acid derivative Am580 Active CN112479918B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202011457051.9A CN112479918B (en) 2020-12-11 2020-12-11 Synthesis method of retinoic acid derivative Am580

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202011457051.9A CN112479918B (en) 2020-12-11 2020-12-11 Synthesis method of retinoic acid derivative Am580

Publications (2)

Publication Number Publication Date
CN112479918A CN112479918A (en) 2021-03-12
CN112479918B true CN112479918B (en) 2023-07-14

Family

ID=74916518

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202011457051.9A Active CN112479918B (en) 2020-12-11 2020-12-11 Synthesis method of retinoic acid derivative Am580

Country Status (1)

Country Link
CN (1) CN112479918B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115646505B (en) * 2022-11-10 2023-12-15 天和药业股份有限公司 Method for preparing aminomethylbenzoic acid by catalytic oxidation of nano-carrier

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0661259A1 (en) * 1994-01-03 1995-07-05 Bristol-Myers Squibb Company Substituted (5,6)-dihydronaphthalenyl compounds having retinoid-like activity
EP1541549A1 (en) * 2003-12-12 2005-06-15 Exonhit Therapeutics S.A. Tricyclic hydroxamate and benzaminde derivatives, compositions and methods
US7321064B1 (en) * 2007-03-08 2008-01-22 Cedarburg Pharmaceuticals, Inc. Preparation of amides of retinoic acid via mixed anhydride and mixed carbonate intermediates
WO2019169270A1 (en) * 2018-03-01 2019-09-06 Dawn Scientific Pharmaceuticals, Llc Bexarotene derivatives and their use in treating cancer

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0661259A1 (en) * 1994-01-03 1995-07-05 Bristol-Myers Squibb Company Substituted (5,6)-dihydronaphthalenyl compounds having retinoid-like activity
EP1541549A1 (en) * 2003-12-12 2005-06-15 Exonhit Therapeutics S.A. Tricyclic hydroxamate and benzaminde derivatives, compositions and methods
US7321064B1 (en) * 2007-03-08 2008-01-22 Cedarburg Pharmaceuticals, Inc. Preparation of amides of retinoic acid via mixed anhydride and mixed carbonate intermediates
WO2019169270A1 (en) * 2018-03-01 2019-09-06 Dawn Scientific Pharmaceuticals, Llc Bexarotene derivatives and their use in treating cancer

Also Published As

Publication number Publication date
CN112479918A (en) 2021-03-12

Similar Documents

Publication Publication Date Title
CN112479918B (en) Synthesis method of retinoic acid derivative Am580
CN112608296A (en) Method for synthesizing brazilanin natural product Brazilane
CN109081822A (en) A kind of method that simplicity prepares high purity butylene phthalide
CN113603653B (en) Synthesis method of selenooxazolidine-2, 4-dione promoted by visible light
CN101293832A (en) Process for synthesizing chlorogenic acid and its derivative
CN101948455A (en) Preparation method of 2-n-butyl-3-(4-hydroxybenzoyl)-5-nitrobenzofuran
CN110845512B (en) Total synthesis method of triterpenoid natural product (+) -Arisugacins F/G
CN111269094B (en) Preparation method of 2-bromo-1, 3-dimethoxybenzene
CN107963976A (en) A kind of preparation method of phenyl ethyl amine compounds intermediate
CN109438327B (en) Fused ring compound and preparation method thereof
Pallavicini et al. Resolution of β-unsaturated amines with isopropylidene glycerol hydrogen phthalate
CN109369442B (en) Preparation method of beta-N-methylamino-L-alanine
CN106749156B (en) Process for preparing benzo [1,3-d ] dioxoles and intermediates thereof
Kobayashi et al. Synthesis of chiral acetic acid by chirality transfer from D-glucose
CN113968798A (en) Cyclohexyl ester compound, preparation method and application thereof
CN110862339A (en) Indole micromolecule compound and preparation method thereof
CN113861202B (en) Large-scale preparation process of pterosin
CN112142595B (en) Preparation method and purification method of ethyl 2,4, 5-trifluoro-benzoylacetate
CN114920635B (en) Preparation method of 4-hydroxy-1-indenone
CN110452097B (en) Preparation method of 1-hydroxypyrene
CN114990590B (en) Novel method for electrocatalytic metal-free transamidation reaction
CN111440059B (en) Synthetic method of loxoprofen
CN110407846A (en) A kind of preparation method of 5- Isosorbide Mononitrate
CN111349012B (en) Preparation method of halogenated aromatic compound and intermediate thereof
CN116813500A (en) Synthesis method of fluorodiclofenac and regorafenib

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant